Mahathir Bayena

J-Star (NASDAQ:YMAT), a company specializing in rackets and technical services, reported unaudited financial results for the six months ended June 30, 2025, showing strong revenue growth of 30.7%, reaching $10.6 million compared to $8.1 million in the same period of 2024.

FactSet (NYSE:FDS) reported solid first-quarter results for fiscal 2026, with GAAP revenues rising 6.9% year-over-year to $607.6 million, and organic revenues increasing 6% to $600 million.

RocketBoots (ASX:ROC) has signed a landmark agreement with a tier-one multinational retailer to deploy its AI-driven loss-prevention solution.

Lumos Diagnostics (ASX:LDX) entered into a new distribution agreement with the Interlux Group to commercialise its FebriDx test across the Baltic region.

FireFly Metals (ASX:FFM) has completed its previously announced equity raising, securing gross proceeds of approximately $139 million before costs.

Bendigo and Adelaide Bank (ASX:BEN) will face a $50 million operational risk capital charge imposed by APRA.

Rincon Resources (ASX:RCR) has signed a multi-stage, multi-year farm-in and joint venture agreement with Greatland Resources (ASX:GGP) over a large portion of its Telfer South tenement package,

OMG Group (ASX: OMG) has reported that half-year group sales for the period to Dec. 31 have surpassed $3 million.

Wiley (NYSE:WLY), a global leader in scientific content and research intelligence, has announced a quarterly cash dividend of $0.355 per share, effective January 15, 2026.

Merck (NYSE:MRK) announced positive topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in patients with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin-based chemotherapy.